Kynam Capital Management, LP
- SEC CIK
- 0001907884
- Latest filing
- Aug 14, 2026
WVE holding history
Wave Life Sciences, Inc. in every 13F filed by Kynam Capital Management, LP, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
WVE overviewAll 13F holders of WVEFull Q2 2026 holdings
- Shares (Q2 2026)
- 0
- Sold out in Q2 2026
- Value
- $0
- % of portfolio
- 0.0%
- Quarters held
- 18
- Since Q4 2021
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q2 2026 | 0 | $0 | 0.0% | −965,193−100.0% | Sold out | Holders |
| Q1 2026 | 965,193 | $7.00M | 0.4% | −1,203,912−55.5% | Reduced | Holders |
| Q4 2025 | 2,169,105 | $36.9M | 2.4% | −2,390,948−52.4% | Reduced | Holders |
| Q3 2025 | 4,560,053 | $33.4M | 2.5% | 00.0% | Unchanged | Holders |
| Q2 2025 | 4,560,053 | $29.6M | 3.2% | −339,444−6.9% | Reduced | Holders |
| Q1 2025 | 4,899,497 | $39.6M | 3.4% | 00.0% | Unchanged | Holders |
| Q4 2024 | 4,899,497 | $60.6M | 4.0% | 00.0% | Unchanged | Holders |
| Q3 2024 | 4,899,497 | $40.2M | 3.1% | +923,976+23.2% | Added | Holders |
| Q2 2024 | 3,975,521 | $19.8M | 2.1% | +43,439+1.1% | Added | Holders |
| Q1 2024 | 3,932,082 | $24.3M | 2.7% | 00.0% | Unchanged | Holders |
| Q4 2023 | 3,932,082 | $19.9M | 2.2% | 00.0% | Unchanged | Holders |
| Q3 2023 | 3,932,082 | $22.6M | 3.8% | +7,480+0.2% | Added | Holders |
| Q2 2023 | 3,924,602 | $14.3M | 2.2% | +116,726+3.1% | Added | Holders |
| Q1 2023 | 3,807,876 | $16.5M | 2.1% | +2,569,694+207.5% | Added | Holders |
| Q4 2022 | 1,238,182 | $8.67M | 1.3% | −159,297−11.4% | Reduced | Holders |
| Q3 2022 | 1,397,479 | $5.04M | 1.1% | −299,256−17.6% | Reduced | Holders |
| Q2 2022 | 1,696,735 | $5.51M | 1.4% | −214,993−11.2% | Reduced | Holders |
| Q1 2022 | 1,911,728 | $3.82M | 1.2% | +417,134+27.9% | Added | Holders |
| Q4 2021 | 1,494,594 | $4.69M | 2.5% | – | No prior filing | Holders |